Please assess the completion status of the following clinical trial:

Trial Title: Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* A maximum body weight of 85.0 kg.~* A minimum body weight of 10 kg for participants aged 2 years to less than 3 years old.~* If female and post-menarchal, or 12 years or older, the subject has a negative urine pregnancy test within 24 hours before surgery.~* Having completed either dental surgery or tonsillectomy with or without adenoidectomy surgery (age group: 6 to less than 18 years of age).~* Having completed ear, nose, or throat surgery (including but not limited to tonsillectomy (age group: 2 to less than 3 years of age).~* Participant aged 6 to less than 18 years has a post-operative pain intensity score greater than or equal to 4 on the Color Analog Scale (CAS) as a result of the surgical procedure or the participant has a pain level that the usual standard of care following the surgical procedure (which reliably produces moderate to severe pain) requires opioid treatment.~* Participant aged 2 years to less than 6 years has a pain level following a surgical procedure that reliably produces moderate to severe pain, for which the usual standard of care requires opioid treatment.~* Participant is alert, orientated, and able to follow commands and complete the post-operative required procedures.~Exclusion Criteria:~* History of brain injury.~* Clinically relevant abnormal ECG.~* Clinically unstable vital signs and/or a saturation of oxygen saturation (SpO2) less than 93%. During surgery SpO2 may decrease \<93%.~* Clinically relevant abnormal values for clinical chemistry, hematology, or urinalysis at enrollment.~* Body temperature above 38.5°C within 48 hours prior to dosing.~* Positive drugs of abuse test result.

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 17 Years
- Healthy Volunteers: f

Study Arms:
- Tapentadol (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).